Medigus Ltd. Series C Warrant
MDGSW
MDGSW was delisted on the 19th of July, 2023.
6 hedge funds and large institutions have $454K invested in Medigus Ltd. Series C Warrant in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
50% more funds holding
Funds holding: 4 → 6 (+2)
42% more capital invested
Capital invested by funds: $319K → $454K (+$135K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$9.19K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$7 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Skaana Management
Brooklyn,
New York
|
-$1.55K |
MDGSW Hedge Fund Activity: Q1 2022 in Review
6 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Medigus Ltd. Series C Warrant (MDGSW) for Q1 2022, worth a combined $454K — up 42% from $319K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new MDGSW positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Warberg Asset Management, opening a new position worth an estimated $9.19K. The largest seller was Skaana Management, cutting an estimated $1.55K.
- 6 institutional investors held Medigus Ltd. Series C Warrant (MDGSW) as of Q1 2022, up from 4 in Q4 2021.
- Funds reported $454K of Medigus Ltd. Series C Warrant stock for Q1 2022, up 42% quarter-over-quarter.
- 2 funds opened new Medigus Ltd. Series C Warrant positions in Q1 2022 and 0 closed out, a net change of +2 holders.
- The largest Medigus Ltd. Series C Warrant buyer in Q1 2022 was Warberg Asset Management, an estimated $9.19K added.
- The largest Medigus Ltd. Series C Warrant seller in Q1 2022 was Skaana Management, an estimated $1.55K sold.
Based on aggregated 13F filings for Q1 2022.